Palliative medicine and the medical oncologist: Defining the purview of care

Hematology/Oncology Clinics of North America

Volumn 10, Issue 1, 1996, Pages 1-20

  Cherny, N I ^a   Catane, R ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER PALLIATIVE THERAPY; EDUCATION PROGRAM; GOOD CLINICAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; MEDICAL SPECIALIST; MENTAL STRESS; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0030048553     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70324-5     Document Type: Article

References (136)

1. N.K. Aaronson S. Ahmedzai B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
2. M.D. Abeloff Burnout in oncology—physician heal thyself J Clin Oncol 9 1991 1721 1722
3. Agency for Health Care Policy and Research Cancer Pain Management Panel: Management of Cancer Pain 1994 US Dept of Health and Human Services, Clinical Practice Guideline No. 9 Washington, DC
4. T.G. Allen Mersh S. Earlam C. Fordy Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases Lancet 344 1994 1255 1260
5. American Society of Clinical Oncology Ad Hoc Committee on Cancer Pain Cancer Pain Assessment and Treatment Curriculum Guidelines J Clin Oncol 10 1992 1976 1982
6. H. Anderson N. Thatcher J. Walling Gemcitabine and palliation of symptoms in non—small cell lung cancer (NSCLC) [meeting abstract 1238] Proc Annu Meet Am Soc Clin Oncol 13 1994 366
7. M. Angell The quality of mercy N Engl J Med 306 1982 98 99
8. M. Ashby The role of radiotherapy in palliative care Journal of Pain and Symptom Management 6 1991 380 388
9. P. Astoul P. Bertault-Peres A. Durand Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion Cancer 73 1994 308 313
10. K. Bjordal S. Kaasa A. Mastekaasa Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy Int J Radiat Oncol Biol Phys 28 1994 847 856
11. N.M. Bleehen D.J. Girling D. Machin A randomised trial of three or six courses of etoposide, cyclophosphamide, methotrexate, and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party Br J Cancer 68 1993 1157 1166
12. J.J. Bonica V. Ventafridda R.G. Twycross Cancer Pain J.J. Bonica The Management of Pain 1990 Lea & Febiger Philadelphia 400 460
13. W. Breitbart Cancer pain and suicide K.M. Foley J.J. Bonica V. Ventafridda Second International Congress on Cancer Pain. Advances in Pain Research and Therapy vol 16 1990 Raven Press New York 399 412
14. W. Breitbart S.D. Passik Psychiatric aspects of palliative care D. Doyle G.W. Hanks N. MacDonald Oxford Textbook of Palliative Medicine 1993 Oxford University Press Oxford 609 626
15. G.P. Browman M.N. Levine D.I. Hodson The Head and Neck Radiotherapy Questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer J Clin Oncol 11 1993 863 872
16. R. Buckman C. De Angelis P. Shaw Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3 Gynecol Oncol 47 1992 102 109
17. J. Bukberg D. Penman J.C. Holland Depression in hospitalized cancer patients Psychosomatic Medicine 46 1984 199 212
18. P. Busch P. Schwendener R.E. Leu Life quality assessment of breast cancer patients receiving adjuvant therapy using incomplete data Health Econ 3 1994 213 220
19. D.J. Case R.M. Bukowski R.W. Carey Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy J Natl Cancer Inst 85 1993 801 806
20. A. Chan R.K. Woodruff Palliative care in a general teaching hospital. 1. Assessment of needs Med J Aust 155 1991 597 599
21. N.I. Cherny N. Coyle K.M. Foley Suffering in the advanced cancer patient: A definition and taxonomy J Palliat Care 10 2 1994 57 70
22. N.I. Cherny H.T. Thaler H. Friedlander-Klar Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled single dose studies Neurology 44 1994 857 861
23. M. Clavel M. Soukop Y.L. Greenstreet Improved control of emesis and quality of life with ondansetron in breast cancer Oncology 50 1993 180 185
24. C.S. Cleeland The impact of pain on the patient with cancer Cancer 54 1984 2635 2641
25. C.S. Cleeland Clinical cancer: 31. Barriers to the management of cancer pain: The roles of patient and family Wis Med J 87 1988 13 5
26. C.S. Cleeland Pain control: Public and physician's attitudes C.S. Hill W.S. Fields Drug Treatment of Cancer Pain in a Drug-Oriented Society. Advances in Pain Research and Therapy vol 11 1989 Raven Press New York 81 89
27. C.S. Cleeland L.M. Cleeland R. Dar Factors influencing physician management of cancer pain Cancer 58 1986 796 800
28. C.S. Cleeland R. Gonin A. Hatfield Pain and its treatment in outpatients with metastatic cancer N Engl J Med 330 1994 592 596
29. C.S. Cleeland J.L. Ladinsky R.C. Serlin Multidimensional measurement of cancer pain: Comparisons of US and Vietnamese patients Journal of Pain and Symptom Management 3 1988 23 27
30. A. Coates V. Gebski J. Bishop Improving quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies N Engl J Med 317 1987 1490 1494
31. A. Coates D. Thomson G.R. McLeod Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma Eur J Cancer 29 1993 1731 1734
32. P.H. Coluzzi M. Grant J.H. Doroshow Survey of the provision of supportive care services at National Cancer Institute—designated cancer centers J Clin Oncol 13 1995 756 764
33. N. Coyle J. Adelhardt K.M. Foley Character of terminal illness in the advanced cancer patient: Pain and other symptoms during last four weeks of life Journal of Pain and Symptom Management 5 1990 83 89
34. W.J. Curran M. Hakki P.J. O'Dwyer Therapeutic responses observed in Phase I trials for adult solid tumors from 1982-1992 [meeting abstract 345] Proc Annu Meet Am Soc Clin Oncol 12 1993 136
35. E.B. Curtis R. Krech T.D. Walsh Common symptoms in patients with advanced cancer J Palliat Care 7 1991 25 29
36. D. Damian M.H. Tattersall Letters to patients: Improving communication in cancer care Lancet 338 1991 923 925
37. R.L. Daut C.S. Cleeland The prevalence and severity of pain in cancer Cancer 50 1982 1913 1918
38. S. Donnelly D. Walsh The symptoms of advanced cancer Semin Oncol 22 Suppl 2 1995 67 72
39. M. Ebert H. Friess H.G. Beger Role of octreotide in the treatment of pancreatic cancer Digestion 1 1994 48 51
40. R. Fainsinger M.J. Miller E. Bruera Symptom control during the last week of life on a palliative care unit J Palliat Care 7 1991 5 11
41. M. Findlay D. Cunningham A. Norman A phase II study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF) Ann Oncol 5 1994 609 616
42. M.P. Findlay D. Cunningham M.E. Hill Protracted venous infusion 5FU + / − interferon-alpha 2b in patients with advanced colorectal cancer: Results of a Phase III trial and a parallel study measuring tumor fluorodeoxyglucose with positron emission tomography [meeting abstract 5591 Proc Annu Meet Am Soc Clin Oncol 13 1994 193
43. B. Fishman S. Pasternak S.L. Wallenstein The Memorial Pain Assessment Card: A valid instrument for the evaluation of cancer pain Cancer 60 1987 1151 1158
44. S.C. Fraser H.J. Dobbs S.R. Ebbs Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life Br J Cancer 67 1993 402 406
45. P.A. Ganz A.C. Schag J.J. Lee Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery Cancer 69 1992 1729 1738
46. D.J. Girling Randomized trial of etoposide, cyclophosphamide, methotrexate and vinscristine versus etoposide and vincristine in the palliative treatment of patients with small-cell lung cancer and poor prognosis [meeting abstract] Br J Cancer 67 1993 14
47. GIVIO Investigators Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial JAMA 271 1994 1587 1592
48. B. Glimelius K. Hoffman W. Graf Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group Cancer 73 1994 556 562
49. S. Greer Can psychological therapy improve the quality of life of patients with cancer? Br J Cancer 59 1989 149 151
50. S. Greer S. Moorey J.D. Baruch Adjuvant psychological therapy for patients with cancer: A prospective randomised trial Br Med J 304 1992 675 680
51. S.A. Grossman V.R. Sheildler K. Swedeen Correlation of patient and caregiver ratings of cancer pain Journal of Pain and Symptom Management 6 1991 53 57
52. S.M. Grunberg P.J. Hesketh Control of chemotherapy-induced emesis N Engl J Med 329 1993 1790 1796
53. T.G. Hall R.A. Schaiff Update on the medical treatment of hypercalcemia of malignancy Clinical Pharmacology 12 1993 117 125
54. L.B. Harrison M.J. Zelefsky J.G. Armstrong Performance status after treatment for squamous cell cancer of the base of tongue—a comparison of primary radiation therapy versus primary surgery Int J Radiat Oncol Biol Phys 30 1994 953 957
55. P.D. Henteleff Symptom prevalence and control during cancer patients' last days of life [letter] J Palliat Care 7 1991 50 51
56. J. Hinton Can home care maintain an acceptable quality of life for patients with terminal cancer and their relatives? Palliat Med 8 1994 183 196
57. J. Hinton Which patients with terminal cancer are admitted from home care? Palliat Med 8 1994 197 210
58. P.J. Hollen R.J. Gralla M.G. Kris Quality of life during clinical trials: Conceptual model for the Lung Cancer Symptom Scale (LCSS) Support Care Cancer 2 1994 213 222
59. K. Holritz A. Lucas Implementation of an anesthesia pain management service program Cancer Practice 1 1993 129 136
60. R. Hultborn I. Terje E. Holmberg Second-line endocrine treatment of advanced breast cancer: A randomized crossover study of medroxyprogesterone acetate and aminoglutethimide [meeting abstract] Ann Oncol 3 1992 75
61. G.A. Johanson Symptom character and prevalence during cancer patients' last days of life Am J Hosp Palliat Care 8 1991 6 8
62. J. Kelly E.C. Holmes G. Rosen Mitoxantrone for malignant pleural effusion due to metastatic sarcoma Surg Oncol 2 1993 299 301
63. A.B. Kornblith D.R. Hollis E. Zuckerman Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B J Clin Oncol 11 1993 2081 2089
64. M.P. Kosty S.B. Fleishman J.E. Herndon II Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: A randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B J Clin Oncol 12 1994 1113 1120
65. F. Labrie A. Dupont L. Cusan Major advantages of early administration of endocrine combination therapy in advanced prostate cancer Clin Invest Med 16 1993 493 498
66. L.R. Laufman R.M. Bukowski M.A. Collier A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer J Clin Oncol 11 1993 1888 1893
67. C.G. Leichman T.R. Fleming F.M. Muggia Fluorouracil (5FU) schedules and modulation in advanced colorectal cancer (CRC): A Southwest Oncology Group (SWOG) screening trial [meeting abstract 5831 Proc Annu Meet Am Soc Clin Oncol 12 1993 198
68. C. Leitgeb M. Pecherstorfer E. Firtz Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin Cancer 73 1994 2535 2542
69. D.N. Levin C.S. Cleeland R. Dan Public attitudes towards cancer pain Cancer 56 1985 2337 2339
70. M.H. Levy Palliative care: Special and deserving of specialty status J Paalliat Care 4 1988 19 22
71. I. Lichter E. Hunt The last 48 hours of life Palliat Care 6 1990 7 15
72. J.N. Lickiss J. Wiltshire P.A. Glare Central Sydney Palliative Care Service: Potential and limitations of an integrated palliative care service based in a metropolitan teaching hospital Ann Acad Med Singapore 23 1994 264 270
73. M. List S.C. Ritter T. Baker A longitudinal assessment of quality of life in laryngeal cancer patients [meeting abstract 916] Proc Annu Meet Am Soc Clin Oncol 13 1994 284
74. C.L. Loprinzi R.M. Goldberg J.Q. Su Placebo—controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer J Clin Oncol 12 1994 1126 1129
75. C.L. Loprinzi S.A. Kuross J.R. O'Fallon Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer J Clin Oncol 12 1994 1121 1125
76. F.R. Macbeth Randomized trial of two radiotherapy policies for patients (pts) with inoperable non—small cell lung cancer and good performance status [meeting abstract] Br J Cancer 67 1993 27
77. N. MacDonald The role of medical and surgical oncology in the management of cancer pain K.M. Foley J.J. Bonica V. Ventafrida Second International Congress on Cancer Pain. Advances in Pain Research and Therapy vol 16 1990 Raven Press New York 27 39
78. N. MacDonald Research—a neglected area of palliative care J Palliat Care 8 1992 54 58
79. N. MacDonald Oncology and palliative care: The case for co-ordination Cancer Treat Rev 19 Suppl A 1993 29 41
80. N. MacDonald Principles governing the use of cancer chemotherapy in palliative medicine D. Doyle G.W. Hanks N. MacDonald Oxford Textbook of Palliative Medicine 1993 Oxford University Press Oxford 105 117
81. D. Machover X. Grison E. Goldschmidt 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens Ann Oncol 4 1993 29 35
82. R.D. MacLeod Education in palliative medicine: A review J Cancer Educ 8 1993 309 312
83. I. Malik Z. Aziz M. Shahid Multicenter trial of single-agent vs combination chemotherapy in metastatic breast cancer [meeting abstract 224] Proc Annu Meet Am Soc Clin Oncol 12 1993 106
84. M.J. Massie J.C. Holland E. Glass Delirium in terminally ill cancer patients Am J Psychiatry 140 1983 1048 1050
85. R. Melzack The McGill pain questionnaire: Major properties and scoring methods Pain 1 1975 277 299
86. G. Michel S. Leyvraz J. Bauer Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer Ann Oncol 5 1994 369 370
87. C.G. Moertel D.L. Ahmann W.F. Taylor Relief of pain by oral medications. A controlled evaluation of analgesic combinations JAMA 229 1974 55 59
88. C.G. Moertel A.J. Schutt R.J. Reitemeier Corticosteroid therapy of preterminal gastrointestinal cancer Cancer 33 1974 1607 1609
89. C.M. Moinpour P. Feigl B. Metch Quality of life endpoints in cancer clinical trials: Review and recommendations J Natl Cancer Inst 81 1989 485 495
90. M.J. Moore D. Osoba K. Murphy Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer J Clin Oncol 12 1994 689 694
91. D.E. Moulin K.M. Foley A review of a hospital based pain service K.M. Foley J.J. Bonica V. Ventafrida Second International Congress of Cancer Pain. Advances in Pain Research and Therapy vol 16 1990 Raven Press New York 413 428
92. S.G. Nayfield P.A. Ganz C.M. Moinpour Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials Qual Life Res 1 1992 203 210
93. E.M. Noordijk C.J. Vecht R.H. Haaxma The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age Int J Radiat Oncol Biol Phys 29 1994 711 717
94. K. Nyman Why palliative care? Aust Fam Physician 23 1994 1197 1199
95. M.E. Osband P.T. Lavin R.K. Babayan Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma Lancet 335 1990 994 998
96. D. Osoba The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: Organization and functions Qual Life Res 1 1992 211 218
97. Osoba D, Zee B, Sadura A, et al. Measurement of quality of life (QOL) in an adjuvant trial of gamma interferon (INF) versus levamisole (LEV) in melanoma [meeting abstract]. 7th International Conference on the Adjuvant Therapy of Cancer, March 1993.
98. L. Ovesen L. Allingstrup J. Hannibal Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study J Clin Oncol 11 1993 2043 2049
99. G.V. Padilla C. Presant M.M. Grant Quality of life index for patients with cancer Research in Nursing and Health 6 1983 117 126
100. R. Portenoy H.T. Thaler A.B. Kornblith The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress Eur J Clin Oncol 30 1994 1326 1336
101. R.K. Portenoy H.T. Thaler A.B. Kornblith Symptom prevalence, characteristics and distress in a cancer population Qual Life Res 3 1994 183 189
102. A.T. Porter A.J. McEwan J.E. Powe Results of a randomized Phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int J Radiat Oncol Biol Phys 25 1993 805 813
103. J.L. Pujol A. Monnier J. Berille Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer Br J Cancer 69 1994 1136 1140
104. K. Pummer H. Stettner M. Lehnert Phase III study of total androgen blockade alone vs combined with weekly epirubicin in advanced prostate cancer [meeting abstract 705] Proc Annu Meet Am Soc Clin Oncol 12 1993 229
105. T.E. Quill C.K. Cassel Nonabandonment: A central obligation for physicians Ann Intern Med 122 1995 368 374
106. B.L. Reele Effect of counseling on quality of life for individuals with cancer and their families Cancer Nurs 17 1994 101 112
107. D.B. Reuben V. Mor J. Hiris Clinical symptoms and length of survival in patients with terminal cancer Arch Intern Med 148 1988 1586 1591
108. K.M. Rowland J.R. Jett S.H. Jung Phase III randomized double blind placebo controlled trial of clisplatin (P) and etoposide (E) plus megestrol acetate (M)/placebo in extensive stage small cell lung (SCLC): A North Central Cancer Treatment Group study [meeting abstract 1092] Proc Annu Meet Am Soc Clin Oncol 13 1994 330
109. J. Santoro T.J. Simpson G. McCormick Treatment of localized pancreatic carcinoma with 5-FU, leucovorin + / − mitomycin, and involved field radiotherapy [meeting abstract 602] Proc Annu Meet Am Soc Clin Oncol 13 1994 204
110. W. Scheithauer H. Rosen G.V. Kronek Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastic colorectal cancer Br Med J 306 1993 752 755
111. H. Schipper J. Clinch A. McMurray Measuring the quality of life of cancer patients: The functional living index—cancer: Development and validation J Clin Oncol 1984 472 483
112. M. Senft R. Fietkau H. Iro The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients Support Care Cancer 1 1993 272 275
113. M.T. Seymour M. Slevin D. Cunningham A randomized assessment of interferonalpha2a (IFNalpha) as a modulator of 5-fluorouracil (5FU) and leucovorin (LV) in advanced colorectal cancer [meeting abstract 621] Proc Annu Meet Am Soc Clin Oncol 13 1994 209
114. R.J. Simes V. Gebski A.S. Coates Quality of life (QOL) with single agent mitozantrone (MTZ) or combination chemotherapy (CMFP) for advanced breast cancer: A randomized trial [meeting abstract 96] Proc Annu Meet Am Soc Clin Oncol 13 1994 73
115. M.Z. Solomon L. O'Donnell B. Jennings Decisions near the end of life: Professional views on life-sustaining treatments Am J Publ Health 83 1993 14 23
116. B.G. Taal F.G. Teller W. ten Bokkel Huinink Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: Experience with two treatment schedules incorporating intravenous or oral etoposide Ann Oncol 5 1994 90 92
117. T. Tate Palliative medicine: Its content and training Br J Hosp Med 44 1990 140 141
118. M.H. Tattersall R.J. Simes T. Lumley Improved quality of life (QOL) with megestrol acetate (MA) for patients with advanced non-endocrine sensitive cancer: A placebo controlled randomized trial [meeting abstract 1497] Proc Annu Meet Am Soc Clin Oncol 13 1994 435
119. O.M. Taylor E.A. Benson M.J. McMahon Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. The Yorkshire Gastrointestinal Tumour Group Br J Surg 80 1993 384 386
120. W.W. ten Bokkel Huinink H. van Tinteren L. Valkenet Treatment of platinum induced anemia in ovarian cancer patients: A controlled study with erythropoietin to prevent anemia and transfusions [meeting abstract 720] Proc Annu Meet Am Soc Clin Oncol 13 1994 234
121. D.B. Thomson M. Adena G.R. McLeod Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial Melanoma Res 3 1993 133 138
122. C.J. Twelves N.A. Dobbs M.A. Lawrence Iododoxorubicin in advanced breast cancer: A phase II evaluation of clinical activity, pharmacology and quality of life Br J Cancer 69 1994 726 731
123. A.T.M. van Holten-Verzantvoort A.H. Zwinderman N.K. Aaronson The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer Eur J Cancer 27 1991 544 549
124. A.T.M. van Holten-Verzantvoort H.M. Kroon O.L. Bijvoet Palliative pamidronate treatment in patients with bone metastases from breast cancer J Clin Oncol 11 1993 491 498
125. V. Ventafridda C. Ripamonti F. De Conno Symptom prevalence and control during cancer patients' last days of life J Palliat Care 6 1990 7 11
126. O. Vinante M. Bari R. Segati The combination of mitomycin, vinblastine and cisplatin is active in the palliation of Stage IIIB-IV non-small-cell lung cancer Oncology 50 1993 1 4
127. J.H. Von Roenn C.S. Cleeland R. Gonin Physician's attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group Ann Intern Med 119 1993 121 126
128. L.M. Wallace S.G. Priestman J.A. Dunn The quality of life of early breast cancer patients treated by two different radiotherapy regimens Clin Oncol (R Coll Radiol) 5 1993 228 333
129. D. Walsh W.J. Gombeski P. Goldsttein Managing a palliative oncology program: The role of a business plan Journal of Pain and Symptom Management 9 1994 109 118
130. S.H. Wanzer D.D. Federman S.J. Adelstein The physician's responsibility toward hopelessly ill patients—a second look N Engl J Med 120 1989 844 849
131. T. Watanabe I. Adachi K. Tajima Improving the quality of life during chemoendocrine therapy for metastatic breast cancer: A randomized comparison of tamoxifen (TAM) vs medroxyprogesterone acetate (MPA) in combination with doxorubicin (ADM) plus cyclophosphamide (CPA) [meeting abstract 90] Proc Annu Meet Am Soc Clin Oncol 13 1994 72
132. D.E. Weissman M. Gutmann J.L. Dahl Physician cancer pain education: A report from the Wisconsin Cancer Pain Initiative Journal of Pain and Symptom Management 6 1991 445 448
133. D.A. Whippen G.P. Canellos Burnout syndrome in the practice of oncology: Result of a random survey of 1000 oncologists J Clin Oncol 9 1991 1916 1920
134. P.A. Wingo T. Tong S. Bolden Cancer statistics, 1995 Ca Cancer J Clin 45 1995 8 30
135. R.K. Woodruff L. Jordan J.P. Eicke Palliative care in a general teaching hospital. 2. Establishment of a service Med J Aust 155 1991 662 665